BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors
Clinical trial NCT04455620 · TERMINATED
Trial details
- NCT number
- NCT04455620
- Sponsor
- BioNTech SE
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2024-05-28
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.